Molecular Network Analysis of the Urinary Proteome of Alzheimer’s Disease Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Molecular Network Analysis of the Urinary Proteome of Alzheimer’s Disease Patients ; volume:9 ; number:1 ; year:2019 ; pages:53-65
Dementia and geriatric cognitive disorders / Extra. Extra ; 9, Heft 1 (2019), 53-65
- Creator
-
Watanabe, Yumi
Hirao, Yoshitoshi
Kasuga, Kensaku
Tokutake, Takayoshi
Semizu, Yuka
Kitamura, Kaori
Ikeuchi, Takeshi
Nakamura, Kazutoshi
Yamamoto, Tadashi
- DOI
-
10.1159/000496100
- URN
-
urn:nbn:de:101:1-2019061300154117012092
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Watanabe, Yumi
- Hirao, Yoshitoshi
- Kasuga, Kensaku
- Tokutake, Takayoshi
- Semizu, Yuka
- Kitamura, Kaori
- Ikeuchi, Takeshi
- Nakamura, Kazutoshi
- Yamamoto, Tadashi
Other Objects (12)
Retinal pathological features and proteome signatures of Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Application of artificial neural network model in diagnosis of Alzheimer’s disease
Synapse loss and progress of Alzheimer’s disease -A network model
Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
Alzheimer disease pathology and the cerebrospinal fluid proteome
Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Retinal pathological features and proteome signatures of Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Application of artificial neural network model in diagnosis of Alzheimer’s disease
Synapse loss and progress of Alzheimer’s disease -A network model
Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
Alzheimer disease pathology and the cerebrospinal fluid proteome
Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Retinal pathological features and proteome signatures of Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease
Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Application of artificial neural network model in diagnosis of Alzheimer’s disease
Synapse loss and progress of Alzheimer’s disease -A network model
Evaluating frontoparietal network topography for diagnostic markers of Alzheimer’s disease
Alzheimer disease pathology and the cerebrospinal fluid proteome
Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease